BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 2 filers reported holding BELLICUM PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $14,000 | +16.7% | 11,026 | 0.0% | 0.00% | – |
| Q3 2019 | $12,000 | -36.8% | 11,026 | 0.0% | 0.00% | – |
| Q2 2019 | $19,000 | -9.5% | 11,026 | +74.3% | 0.00% | – |
| Q1 2019 | $21,000 | -22.2% | 6,326 | -30.7% | 0.00% | – |
| Q4 2018 | $27,000 | -70.7% | 9,132 | -39.0% | 0.00% | -100.0% |
| Q3 2018 | $92,000 | -51.1% | 14,969 | -41.2% | 0.00% | -50.0% |
| Q2 2018 | $188,000 | +1466.7% | 25,475 | +1309.8% | 0.00% | – |
| Q1 2018 | $12,000 | -45.5% | 1,807 | -31.7% | 0.00% | – |
| Q4 2017 | $22,000 | -89.8% | 2,644 | -85.8% | 0.00% | -100.0% |
| Q3 2017 | $215,000 | +497.2% | 18,574 | +502.5% | 0.00% | – |
| Q2 2017 | $36,000 | +227.3% | 3,083 | +285.4% | 0.00% | – |
| Q4 2016 | $11,000 | – | 800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 220,000 | $5,069,000 | 3.43% |
| Perceptive Advisors | 1,046,402 | $24,109,000 | 2.02% |
| Redmile Group, LLC | 860,809 | $17,269,000 | 1.88% |
| Baker Brothers Advisors | 4,283,732 | $98,697,000 | 1.01% |
| RA Capital Management | 1,026,402 | $9,337,000 | 1.00% |
| Ghost Tree Capital, LLC | 75,000 | $1,728,000 | 0.83% |
| ACUTA CAPITAL PARTNERS, LLC | 45,750 | $1,054,000 | 0.71% |
| GREAT POINT PARTNERS LLC | 50,000 | $1,152,000 | 0.55% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 167,210 | $3,853,000 | 0.33% |
| EMERALD ADVISERS, LLC | 198,202 | $4,567,000 | 0.24% |